By: Benzinga
Cyberonics Issues Update on CMS Submission, Says Hasn't Received Formal Response
Cyberonics, Inc. (NASDAQ: CYBX ) today provided an update on its recent submission to the Centers for Medicare & Medicaid Services ("CMS") seeking reimbursement coverage for the treatment-resistant depression ("TRD") indication for the VNS Therapy^® System. As previously announced, the company submitted a request to CMS for reconsideration of coverage for VNS Therapy for TRD
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here